We are live on ! Find out more
AKBA icon

Akebia Therapeutics
AKBA

153 hedge funds and large institutions have $412M invested in Akebia Therapeutics in 2018 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 49 increasing their positions, 37 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,347% more call options, than puts

Call options by funds: $3.24M | Put options by funds: $224K

115% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 20

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

32% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 37

16% more funds holding

Funds holding: 132 → 153 (+21)

6.08% more ownership

Funds ownership: 71.29% → 77.36% (+6.1%)

12% less capital invested

Capital invested by funds: $470M → $412M (-$58.5M)

Holders
153
Holders Change
+21
Holders Change %
+15.91%
% of All Funds
3.51%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
43
Increased
49
Reduced
37
Closed
20
Calls
$3.24M
Puts
$224K
Net Calls
+$3.02M
Net Calls Change
+$2.81M

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$20.3M
2
EC
EcoR1 Capital
California
+$19.9M
3
LCM
Laurion Capital Management
New York
+$13.5M
4
NHAS
Novo Holdings A/S
Denmark
+$12.2M
5
Renaissance Technologies
Renaissance Technologies
New York
+$9.76M

Top Sellers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
-$12.3M
2
Millennium Management
Millennium Management
New York
-$5.13M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$4.54M
4
Norges Bank
Norges Bank
Norway
-$3.49M
5
EI
EAM Investors
California
-$2.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
51
Sabby Management
Florida
$975K +$1.43M +102,338 New
Ameriprise
52
Ameriprise
Minnesota
$825K -$1.14M -81,627 -49%
Jacobs Levy Equity Management
53
Jacobs Levy Equity Management
New Jersey
$794K +$656K +46,909 +129%
Two Sigma Advisers
54
Two Sigma Advisers
New York
$788K -$22.4K -1,600 -2%
TA
55
Teachers Advisors
New York
$767K – – –
AIMCA
56
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$752K +$498K +35,600 +82%
Swiss National Bank
57
Swiss National Bank
Switzerland
$744K +$193K +13,800 +21%
SCA
58
Secor Capital Advisors
New York
$665K +$298K +21,314 +44%
California State Teachers Retirement System (CalSTRS)
59
California State Teachers Retirement System (CalSTRS)
California
$648K -$35.2K -2,520 -4%
Los Angeles Capital Management
60
Los Angeles Capital Management
California
$627K +$111K +7,925 +14%
AA
61
ALPS Advisors
Colorado
$604K +$154K +11,019 +21%
JIC
62
Johnson Investment Counsel
Ohio
$586K +$1.47K +105 +0.2%
California Public Employees Retirement System
63
California Public Employees Retirement System
California
$581K – – –
ARTA
64
A.R.T. Advisors
New York
$556K +$816K +58,371 New
Bank of Montreal
65
Bank of Montreal
Ontario, Canada
$555K -$131K -9,361 -14%
AIM
66
Assured Investment Management
New York
$554K +$814K +58,167 New
FP
67
Foundry Partners
Minnesota
$522K +$766K +54,741 New
CS
68
Credit Suisse
Switzerland
$506K +$116K +8,298 +19%
New York State Common Retirement Fund
69
New York State Common Retirement Fund
New York
$502K – – –
Arrowstreet Capital
70
Arrowstreet Capital
Massachusetts
$500K +$734K +52,500 New
Squarepoint
71
Squarepoint
New York
$494K +$196K +13,996 +37%
SO
72
STRS Ohio
Ohio
$492K – – –
VEA
73
Virtus ETF Advisers
New York
$481K +$378K +27,003 +115%
OPPM
74
Opus Point Partners Management
New York
$477K +$406K +28,995 +138%
Russell Investments Group
75
Russell Investments Group
United Kingdom
$440K +$93.2K +6,663 +17%
1 2
3
4 5

AKBA Hedge Fund Activity: Q1 2018 in Review

153 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q1 2018, worth a combined $412M — down 12% from $470M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new AKBA positions and 20 closed out — a net gain of 23 holders — while 49 added to existing stakes and 37 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $20.3M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $12.3M sold.

  • 153 institutional investors held Akebia Therapeutics (AKBA) as of Q1 2018, up from 132 in Q4 2017.
  • Funds reported $412M of Akebia Therapeutics stock for Q1 2018, down 12% quarter-over-quarter.
  • 43 funds opened new Akebia Therapeutics positions in Q1 2018 and 20 closed out, a net change of +23 holders.
  • The largest Akebia Therapeutics buyer in Q1 2018 was Nantahala Capital Management, an estimated $20.3M added.
  • The largest Akebia Therapeutics seller in Q1 2018 was Farallon Capital Management, an estimated $12.3M sold.

Based on aggregated 13F filings for Q1 2018.